In the BioHarmony Drug Report Database

"Preview" Icon

Colistimethate

Coly-mycin M, Colobreathe (colistimethate) is an unknown pharmaceutical. Colistimethate was first approved as Coly-mycin M on 1982-01-01. It is used to treat bacterial infections, escherichia coli infections, klebsiella infections, pseudomonas infections, and urinary tract infections in the USA. It has been approved in Europe to treat cystic fibrosis.

 

Trade Name

 

Colobreathe
 

Common Name

 

colistimethate
 

ChEMBL ID

 

CHEMBL2304327
 

Indication

 

bacterial infections, cystic fibrosis, escherichia coli infections, klebsiella infections, pseudomonas infections, urinary tract infections
 

Drug Class

 

Image (chem structure or protein)

Colistimethate structure rendering